Apixaban and aspirin are comparable in protection against major ischemic or hemorrhagic events in patients with cancer history and cryptogenic stroke.
Higher disease activity and inflammatory markers were associated with an increased risk for MACE among patients with RA not using bDMARDs.
The USPSTF released a recommendation statement regarding screening and supplementation for iron deficiency, both with and without anemia, in the setting of pregnancy.